The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis

Glioma is the most prevalent primary brain tumor. Immune checkpoint blockade has made a great stride in mending patient’s clinical outcome for multiple types of cancers. However, PD-1, CTLA-4, or VEGF blockade exhibited only poor outcome in glioma patients. This study aimed to explore the expression...

Full description

Bibliographic Details
Main Authors: Amina Ghouzlani, Soumaya Rafii, Mehdi Karkouri, Abdelhakim Lakhdar, Abdallah Badou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
IgSF11
PDL-1
VISTA
glioma
glioblastoma
immune checkpoint
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.608609/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.608609/full

Similar Items